# Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population

> **NCT07401680** · PHASE1 · RECRUITING · sponsor: **University of Alberta** · enrollment: 85 (estimated)

## Conditions studied

- Ulcerative Colitis
- Inflammatory Bowel Diseases
- Clostridioides Difficile Infection

## Interventions

- **OTHER:** Lyophilized Fecal Microbiota Transplantation (LFMT)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07401680
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2028-03-01
- **Final completion:** 2028-12-01
- **Target enrollment:** 85 (ESTIMATED)
- **Last updated:** 2026-05-08

## Collaborators

- University of Calgary

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07401680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07401680, "Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population". Retrieved via AI Analytics 2026-05-20 from https://api.ai-analytics.org/clinical/NCT07401680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*